ArticleVaccines2023
Older Age, a High Titre of Neutralising Antibodies and Therapy with Conventional DMARDs Are Associated with Protection from Breakthrough Infection in Rheumatoid Arthritis Patients after the Booster Dose of Anti-SARS-CoV-2 Vaccine.
Open access · goldAbstract read
In one paragraph
Article in Vaccines, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.2field-weighted citation impact, top 22% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed, 6 citations in OpenAlex.
- Evaluating SARS-CoV-2 T Cell Immunity in COVID-19-Naive Vaccinated Individuals with and Without Spike Protein IgG Antibodies.Pathogens (Basel, Switzerland) · 2025Article
- Article
- Effectiveness and Safety of the COVID-19 Vaccine in Patients with Rheumatoid Arthritis in a Real-World Setting.Vaccines · 2024Article
- Protecting the vulnerable: addressing the COVID-19 care needs of people with compromised immunity.Frontiers in immunology · 2024Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
30 authors at 5 institutions in 1 country.
Andrea Picchianti-DiamantiDepartment of Clinical and Molecular Medicine, "Sapienza" University, S. Andrea University Hospital, 00189 Rome, Italy.ORCID 0000-0002-8552-4641
Assunta NavarraEpidemiology Department, National Institute for Infectious Diseases Lazzaro Spallanzani-Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), 00149 Rome, Italy.ORCID 0000-0002-3662-4312
Alessandra AielloTranslational Research Unit, National Institute for Infectious Diseases Lazzaro Spallanzani-Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), 00149 Rome, Italy.ORCID 0000-0003-2681-9383
Bruno LaganàDepartment of Clinical and Molecular Medicine, "Sapienza" University, S. Andrea University Hospital, 00189 Rome, Italy.ORCID 0000-0003-2305-4063
Gilda CuzziTranslational Research Unit, National Institute for Infectious Diseases Lazzaro Spallanzani-Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), 00149 Rome, Italy.
Andrea SalmiTranslational Research Unit, National Institute for Infectious Diseases Lazzaro Spallanzani-Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), 00149 Rome, Italy.
Valentina VaniniTranslational Research Unit, National Institute for Infectious Diseases Lazzaro Spallanzani-Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), 00149 Rome, Italy.
Fabrizio MaggiLaboratory of Virology, National Institute for Infectious Diseases Lazzaro Spallanzani-Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), 00149 Rome, Italy.ORCID 0000-0001-7489-5271
Silvia MeschiLaboratory of Virology, National Institute for Infectious Diseases Lazzaro Spallanzani-Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), 00149 Rome, Italy.ORCID 0000-0003-0924-993X
Giulia MatusaliLaboratory of Virology, National Institute for Infectious Diseases Lazzaro Spallanzani-Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), 00149 Rome, Italy.ORCID 0000-0002-2948-4243
Stefania NotariLaboratory of Cellular Immunology and Clinical Pharmacology, National Institute for Infectious Diseases Lazzaro Spallanzani-Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), 00149 Rome, Italy.
Chiara AgratiLaboratory of Cellular Immunology and Clinical Pharmacology, National Institute for Infectious Diseases Lazzaro Spallanzani-Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), 00149 Rome, Italy.
Simonetta SalemiDepartment of Clinical and Molecular Medicine, "Sapienza" University, S. Andrea University Hospital, 00189 Rome, Italy.
Roberta Di RosaDepartment of Clinical and Molecular Medicine, "Sapienza" University, S. Andrea University Hospital, 00189 Rome, Italy.
Damiano PassariniDepartment of Clinical and Molecular Medicine, "Sapienza" University, S. Andrea University Hospital, 00189 Rome, Italy.
Valeria Di GioiaDepartment of Clinical and Molecular Medicine, "Sapienza" University, S. Andrea University Hospital, 00189 Rome, Italy.
Giorgio SestiDepartment of Clinical and Molecular Medicine, "Sapienza" University, S. Andrea University Hospital, 00189 Rome, Italy.ORCID 0000-0002-1618-7688
Fabrizio ContiReumatologia, Dipartimento di Scienze Cliniche Internistiche, Anestesiologiche e Cardiovascolari, "Sapienza" Università di Roma, 00161 Rome, Italy.
Francesca Romana SpinelliReumatologia, Dipartimento di Scienze Cliniche Internistiche, Anestesiologiche e Cardiovascolari, "Sapienza" Università di Roma, 00161 Rome, Italy.ORCID 0000-0003-1969-2097
Angela CorpolongoClinical Division of Infectious Diseases, National Institute for Infectious Diseases Lazzaro Spallanzani-Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), 00149 Rome, Italy.
Maria Sole ChimentiRheumatology, Allergology and Clinical Immunology, Department of 'Medicina dei Sistemi', University of Rome 'Tor Vergata', 00133 Rome, Italy.ORCID 0000-0002-1343-1729
Mario FerraioliDepartment of Rheumatology, San Camillo Hospital, 00152 Rome, Italy.
Gian Domenico SebastianiDepartment of Rheumatology, San Camillo Hospital, 00152 Rome, Italy.
Maurizio BenucciRheumatology Unit, S. Giovanni di Dio Hospital, Azienda USL-Toscana Centro, 50122 Florence, Italy.
Francesca Li GobbiRheumatology Unit, S. Giovanni di Dio Hospital, Azienda USL-Toscana Centro, 50122 Florence, Italy.
Anna Paola SantoroUOC Emerging Infections and Centro di Riferimento AIDS (CRAIDS), National Institute for Infectious Diseases Lazzaro Spallanzani-Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), 00149 Rome, Italy.
Andrea CapriUOC Emerging Infections and Centro di Riferimento AIDS (CRAIDS), National Institute for Infectious Diseases Lazzaro Spallanzani-Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), 00149 Rome, Italy.
Vincenzo PuroUOC Emerging Infections and Centro di Riferimento AIDS (CRAIDS), National Institute for Infectious Diseases Lazzaro Spallanzani-Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), 00149 Rome, Italy.ORCID 0000-0003-0291-4490
Emanuele NicastriClinical Division of Infectious Diseases, National Institute for Infectious Diseases Lazzaro Spallanzani-Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), 00149 Rome, Italy.ORCID 0000-0002-5606-8712
Delia GolettiTranslational Research Unit, National Institute for Infectious Diseases Lazzaro Spallanzani-Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), 00149 Rome, Italy.ORCID 0000-0001-8360-4376
Istituto Nazionale per le Malattie Infettive Lazzaro Spallanzani · ITSapienza University of Rome · ITAzienda Usl Toscana Centro · ITIRCCS San Camillo Hospital · ITUniversity of Rome Tor Vergata · IT
Funding
Associazione magistrati della Corte dei Conti generous liberal donation/funding for COVID-19 researchCamera di Commercio, Industria e Artigianato di Roma generous liberal donation/funding for COVID-19 researchFineco Bank S.p.A generous liberal donation/funding for COVID-19 researchMinistero della Salute Ricerca Corrente on emerging infectionsSocietà Mocerino Frutta Secca s.r.l generous liberal donation/funding for COVID-19 researchSocietà Numero Blu Servizi S.p.A generous liberal donation/funding for COVID-19 researchSocietà Valentino S.p.A generous liberal donation/funding for COVID-19 research
Abstract
PubMed holds no abstract for this paper.
Indexed as
boosterimmunogenicityimmunosuppressive therapyneutralising antibodiesprotective immunityrheumatoid arthritisSARS-CoV-2vaccine
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.